blockchain

Introduction On May 22nd 2024, I was please to be able to attend an industry roundtable looking at tokenizing the UK’s digital economy. This meeting (agenda and main areas for discussion above) was held on an “interesting” and very wet day in the Palace of Westminster (the beginning of the meeting was delayed and then […]

All-Party Parliamentary Group on Blockchain Technologies : Insights from a ...

 in blog  tagged APPG / blockchain / DeFi / digital identity / DLT / SSI / Web3 by
Ever since blockchain burst onto the scene a decade ago as a technology primarily designed for use in the financial services industry, people have continually found new—and sometimes odd—applications for the technology. Blockchain has been applied to everything from “buying” time (sic!) to renting a supercomputer, yet when it comes to the life sciences, a […]

The Future Of Blockchain: The Use Cases Set To Reshape ...

 in blog  tagged API / blockchain / clinical / consent / life science / pharmaceuticals / sharing by
Ahead of Bio-IT World Expo 2019 (#BioIT19), Richard Shute from Curlew Research is interviewed by Bio-IT World on the ever-growing potential for blockchain and distributed ledger technology (DLT) in life sciences. Blockchain has great potential within the clinical arena to support enhanced data management at nearly every level, he maintains. Added to this its potential […]

Blockchain – Not Just For Bitcoin

 in Uncategorized  tagged blockchain / clinical / DLT / healthcare / life science / pharmaceuticals by
In a new article published on LinkedIn, Richard Shute, Curlew Research Consultant, explains why he believes blockchain and distributed ledger technology (DLT) can play a significant role in the good practice areas of the GxP domain to enhance compliance, quality and safety through improved trust and confidence. He explores how this can be accomplished by […]

Blockchain, Distributed Ledger Technology and GxP: The Trust Protocol Enhancing ...

 in blog  tagged blockchain / compliance / GxP / pharmaceuticals / regulatory by
2
Reputation, corporate and personal, is an intangible asset of immense value. Building a positive reputation can be time-consuming, costly and difficult. Having your reputation ruined can, contrarily, be horribly easy and take but a moment. That is why corporations the world over – pharmaceutical companies and healthcare organizations are no exceptions – spend a lot […]

Blockchain and corporate reputation: could distributed ledger technology help (re)build ...

 in blog  tagged blockchain / corporate reputation / healthcare by
We are delighted to be supporting the Pistoia Alliance Blockchain Bootcamp in Boston The Pistoia Alliance Blockchain Bootcamp is part of the Pistoia Alliance’s blockchain education efforts. Coming out of the event we expect our attendees will have a much better understanding of the technology, and can start more effectively evaluating if/how blockchain could be […]

Blockchain Bootcamp

 tagged blockchain by
When it comes to blockchain technology in R&D, clearly: “It’s All About The Data Sharing”! This is the main conclusion that has come out from a Pistoia Alliance assessment of blockchain applications in life sciences R&D managed by Richard Shute of Curlew Research for The Alliance. Over 75 scientists and developers from Big Pharma, informatics software […]

“It’s All About The Data Sharing!” Pistoia Alliance’s “Blockchain in ...

 in blog  tagged blockchain / data / healthcare / integrity / R&D / sharing by